Unsecured Convertible Notes definition
Examples of Unsecured Convertible Notes in a sentence
Unsecured 2022 Convertible Notes The 8.125% convertible notes due October 16, 2022, issued pursuant to that certain Indenture dated April 17, 2012, by and among ▇▇▇▇▇▇▇▇▇, as issuer; certain of ▇▇▇▇▇▇▇▇▇’▇ Subsidiaries, as guarantors; and the Unsecured Convertible Notes Trustee.
That certain Indenture dated June 29, 2015 between Borrower and Computershare Trust Company, N.A., as registrar, paying agent and conversion agent, and Computershare Trust Company, N.A., as trustee, as supplemented by a Supplemental Indenture dated June 29, 2015, governing the Senior Unsecured Convertible Notes.
The Notes shall be designated as “1.0% Guaranteed Senior Unsecured Convertible Notes due 2012”.
This Security is one of a duly authorized issue of Securities of the Company designated as its 8.50% Senior Unsecured Convertible Notes due 2019 (the “Securities”), issued under an Indenture, dated as of February 21, 2014 (together with any supplemental indentures thereto, the “Indenture”), among the Company and the Trustee.
This Unsecured Convertible Note (including all Unsecured Convertible Notes issues in exchange, transfer, or replacement hereof, this “Note”) is one of an issue of Unsecured Convertible Notes issued pursuant to the Securities Purchase Agreement (as defined below) on the Closing Date (as defined in the Securities Purchase Agreement) (collectively, the “Notes” and such other Unsecured Convertible Notes, the “Other Notes”).
The Company is entering into a Note Purchase Agreement (the "NOTE PURCHASE AGREEMENT") dated as of the date hereof, with the Purchasers, pursuant to which the Company is issuing to the Purchasers up to $3,000,000 million aggregate principal amount of its 10% Senior Unsecured Convertible Notes due November 2003 (and currently proposed to be December 2003).
This Security is one of a duly authorized issue of Securities of the Company designated as its 5.00% Senior Unsecured Convertible Notes due 2023 (the “Securities”), issued under an Indenture, dated as of [ ], 2017 (together with any supplemental indentures thereto, the “Indenture”), among the Company and the Trustee.
At the appropriate undersigned’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of the New Warrants or Unsecured Convertible Notes, as the case may be, may reasonably request in connection with a pledge or transfer of the New Warrants, the Unsecured Convertible Notes or Underlying Shares.
Subject to the terms and conditions of this Agreement, the Company will, on the Closing Date, (i) issue and sell to the Purchaser, and the Purchaser will purchase from the Company, the Company’s 600 Guaranteed Senior Unsecured Convertible Notes due 2012 (the “Notes”) of US$100,000 principal amount each, convertible into shares of Common Stock, at an initial conversion price of US$18.00 per share, and (ii) cause the Guarantors to issue the Guarantees.
This Amendment No. 5 to Tranche A Senior Unsecured Convertible Notes and Tranche B Senior Unsecured Convertible Notes (this “Amendment”) is entered into effective as of January 31, 2012 (the “Effective Date”), by and among Genesis Biopharma, Inc., a Nevada corporation (the “Company”), and the parties set forth on the signature page hereto as the “Holders” (the “Holders”).